ZHONGHENG GROUP(SH:600252) Xin Lang Cai Jing·2025-12-23 06:24Group 1 - The core viewpoint of the news is that Zhongheng Group's stock has experienced fluctuations, with a recent decline of 2.09% and a year-to-date increase of 14.23% [1] - As of December 23, the stock price is reported at 2.81 yuan per share, with a total market capitalization of 8.979 billion yuan [1] - The company has seen a net outflow of main funds amounting to 7.8353 million yuan, with significant selling pressure observed [1] Group 2 - Zhongheng Group, established on July 28, 1993, and listed on November 30, 2000, operates in various sectors including pharmaceuticals, energy, infrastructure, and real estate [2] - The company's main business revenue composition includes 66.19% from pharmaceutical sales, 19.21% from food sales, and 5.58% from daily chemical products [2] - As of September 30, the company reported a revenue of 1.948 billion yuan for the first nine months of 2025, reflecting a year-on-year growth of 1.10%, and a net profit of 24.6404 million yuan, up 119.61% year-on-year [2] Group 3 - Zhongheng Group has distributed a total of 2.941 billion yuan in dividends since its A-share listing, with 68.7428 million yuan distributed in the last three years [3] - As of September 30, 2025, the number of shareholders increased by 3.54% to 119,000, while the average circulating shares per person decreased by 6.87% to 26,766 shares [2][3] - Notable institutional shareholders include Southern CSI 1000 ETF and Hong Kong Central Clearing Limited, with some shareholders reducing their holdings [3]